Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Heterologous human adult liver-derived stem cells

EU orphan designation number: EU/3/11/904   
Active ingredient: Heterologous human adult liver-derived stem cells
Indication: Treatment of ornithine transcarbamylase deficiency
Sponsor: Fresenius Medical Care Deutschland GmbH
Else-Kröner-Straße 1, D-61352 Bad Homburg v.d. Höhe, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/09/2011 Centralised Orphan - Designation EMA/OD/026/11 (2011)7037 of 27/09/2011